Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017ThrombosisCLLMultiple Myeloma
Cyclophosphamide after transplant reduced GVHD in myeloma patientsNovember 20, 2017Multiple MyelomaCellular Therapy
Multiple myeloma patients with t(11;14) respond best to venetoclax monotherapyOctober 12, 2017Multiple Myeloma
Tailored approaches to relapsed/recalcitrant myeloma found within NCCN guidelinesOctober 12, 2017Multiple Myeloma
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65September 20, 2017Multiple Myeloma
Lenalidomide maintenance boosts survival in de novo myeloma after ASCTAugust 15, 2017Multiple Myeloma
Less lenalidomide may be more in frail elderly multiple myeloma patientsJuly 27, 2017Multiple Myeloma
FDA okays ClearLLab test for hematologic cancer detectionJuly 11, 2017Multiple MyelomaMyelodysplastic Syndrome
